Suchergebnisse - "Hu, Xiaolei"

PubPharm (297)

61

A genomic and transcriptomic study toward breast cancer

enthalten in: Frontiers in genetics | 2022

von Wang, S. | Shang, P. | Yao, G. | +3

62

Safety and efficacy of remimazolam besylate in patients undergoing colonoscopy : A multicentre, single-blind, randomized, controlled, phase Ⅲ trial

enthalten in: Frontiers in pharmacology | 2022

von Wang, X. | Hu, X. | Bai, N. | +4

63

Autoimmune Polyendocrinopathy Induced by an Antibody (KN046) That Simultaneously Inhibits PD-L1 and CTLA-4 : A Case Report and Literature Review

enthalten in: Diabetes, metabolic syndrome and obesity : targets and therapy | 2022

von Li, M. | Wu, C. | Liu, Y. | +5

64

Assessments of a novel digital follow-up tool Rehabkompassen® to identify rehabilitation needs among stroke patients in an outpatient setting

enthalten in: Digital health | 2022

von Hu, X. | Jonzén, K. | Karlsson, M. | +1

65

High expression of P4HA3 in obesity : a potential therapeutic target for type 2 diabetes

enthalten in: Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas | 2022

von Zhuang, L. | Li, C. | Hu, X. | +3

66

Safety and efficacy of compound methyl salicylate liniment for topical pain : A multicenter real-world study in China

enthalten in: Frontiers in pharmacology | 2022

von Guo, J. | Hu, X. | Wang, J. | +7

67

TSPAN8 alleviates high glucose‐induced apoptosis and autophagy via targeting mTORC2

enthalten in: Cell Biology International | 2022

von Zhuang, L. | Jin, G. | Hu, X. | +3

68

Additional adjuvant capecitabine in early breast cancer patients : a meta-analysis of randomized controlled trials

enthalten in: Future oncology (London, England) | 2021

von Zhou, W. | Cao, Y. | Gou, P. | +6

69

Clinical characteristics and associating risk factors of gastrointestinal perforation in children with IgA vasculitis

enthalten in: Annals of medicine | 2021

von Guo, Q. | Hu, X. | Song, C. | +7

70

Lenvatinib enhances T cell immunity and the efficacy of adoptive chimeric antigen receptor-modified T cells by decreasing myeloid-derived suppressor cells in cancer

enthalten in: Pharmacological research | 2021

von Lu, M. | Zhang, X. | Gao, X. | +11